Biostage
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Biostage generated cash of -$6,939,000, which is less than the previous year. Cash used in financing activities reached the amount of $6,141,000 last year. Net change in cash is therefore -$809,000.
Cash Flow
| 2014 | -7.99M | -1.16M | 418K |
|---|---|---|---|
| 2015 | -7.18M | -175K | 9.55M |
| 2016 | -9.05M | -302K | 4.84M |
| 2017 | -11.01M | -136K | 12.24M |
| 2018 | -7.63M | -67K | 5.02M |
| 2019 | -6.05M | -129K | 5.79M |
| 2020 | -4.04M | -7K | 4.16M |
| 2021 | -2.62M | 0 | 2.84M |
| 2022 | -5.10M | -5K | 5.06M |
| 2023 | -6.93M | -11K | 6.14M |
BSTG Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.24M | 1.29M | 1.07M | 963K | 1.35M | 4.03M | 2.94M | 7.45M | 5.27M | 14.00M |
Operating activities | ||||||||||
Net income | -8.94M | -6.07M | -7.97M | -4.86M | -8.33M | -7.52M | -11.91M | -11.57M | -11.70M | -11.06M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 134K | 52K | 107K | 184K | 311K | 261K | 413K | 454K | 478K | 363K |
Stock-based compensation expense | 0 | 1.03M | 980K | 1.14M | 1.65M | 755K | 693K | 1.32M | 3.96M | 2.56M |
| Deferred income tax benefit | 0 | 1.03M | 980K | 1.14M | 1.65M | 755K | 693K | 1.32M | 3.96M | 2.56M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -4K | 0 | 0 | 0 | 0 | 0 | 42K | -21K | -16K | -5K |
Inventories | -50K | 0 | 0 | 0 | 0 | 0 | 0 | 75K | 132K | -169K |
Accounts payable | -237K | 6K | 645K | -210K | 81K | -763K | -43K | 472K | -13K | 126K |
Cash generated by operating activities | -6.93M | -5.10M | -2.62M | -4.04M | -6.05M | -7.63M | -11.01M | -9.05M | -7.18M | -7.99M |
Investing activities | ||||||||||
Purchases Of Investments | -2.52M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -11K | -5K | 0 | -7K | -129K | -131K | -136K | -302K | -176K | -1.16M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -11K | -5K | 0 | -7K | -129K | -67K | -136K | -302K | -175K | -1.16M |
Financing activities | ||||||||||
Common Stock Issued | 5.99M | 5.06M | 2.84M | 1.05M | 1.80M | 5.32M | 6.80M | 4.84M | 9.55M | 418K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -42K | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 6.14M | 5.06M | 2.84M | 4.16M | 5.79M | 5.02M | 12.24M | 4.84M | 9.55M | 418K |
Net Change In Cash | -809K | -51K | 216K | 113K | -392K | -2.68M | 1.09M | -4.51M | 2.18M | -8.73M |
Cash at end of period | 432K | 1.24M | 1.29M | 1.07M | 963K | 1.35M | 4.03M | 2.94M | 7.45M | 5.27M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |